68 related articles for article (PubMed ID: 34101206)
1. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
[TBL] [Abstract][Full Text] [Related]
2. Novel 532-nm Q-switched Nd: YAG laser for the treatment of melasma and rejuvenation: a prospective, randomized controlled comparison with 1,064-nm Q-switched Nd: YAG laser.
Wu W; Su Q; Zhang Y; Du Y; Hu Y; Wang F
Int J Dermatol; 2024 Feb; ():. PubMed ID: 38411341
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
Zhou Y; Li Y; Hamblin MR; Wen X
Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
[TBL] [Abstract][Full Text] [Related]
4. Low Fluence Q-Switched Nd: YAG Laser Toning and Q-Switched Ruby Laser in the Treatment of Melasma:A Comparative Split-Face Ultrastructural Study.
Omi T; Yamashita R; Kawana S; Sato S; Naito Z
Laser Ther; 2012 Mar; 21(1):15-4. PubMed ID: 24610976
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis.
Feng J; Shen S; Song X; Xiang W
Lasers Med Sci; 2023 Mar; 38(1):84. PubMed ID: 36897459
[TBL] [Abstract][Full Text] [Related]
6. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of laser-related therapy for melasma: A systematic review and network meta-analysis.
Ma W; Gao Q; Liu J; Zhong X; Xu T; Wu Q; Cheng Z; Luo N; Hao P
J Cosmet Dermatol; 2023 Nov; 22(11):2910-2924. PubMed ID: 37737021
[TBL] [Abstract][Full Text] [Related]
8. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array.
Bernstein EF; Basilavecchio LD; Wang J
Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307
[TBL] [Abstract][Full Text] [Related]
9. Using reflectance confocal microscopy to observe in vivo melanolysis after treatment with the picosecond alexandrite laser and Q-switched Nd:YAG laser in melasma.
Jo DJ; Kang IH; Baek JH; Gwak MJ; Lee SJ; Shin MK
Lasers Surg Med; 2019 Jul; 51(5):423-429. PubMed ID: 30351494
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of home-based 590 nm light-emitting diodes and in-hospital 1064 nm Q-switched Nd:YAG laser in the treatment of facial melasma: A single-centre, prospective, randomized clinical trial.
Xuan YJ; Dai XX; Chen L; Xiang LH; Jin SL; Zhang CF
J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):e162-e164. PubMed ID: 37703182
[No Abstract] [Full Text] [Related]
11. Evaluation and comparison of Q-switched Nd: YAG laser 1064 nm and Er: YAG laser 2940 nm in the treatment of macular amyloidosis.
Mokhtari F; Yazdanpanah M; Iraji F; Asilian A; Siadat A; Tavakolifard N
Lasers Med Sci; 2024 Jan; 39(1):22. PubMed ID: 38165508
[TBL] [Abstract][Full Text] [Related]
12. Treatment Indications of Carbon Solution-Assisted Nd: YAG Laser According to Patient Satisfaction: A Retrospective Study.
Hügül H; Özkoca D; Kirişci M; Kutlubay Z
Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992373
[TBL] [Abstract][Full Text] [Related]
13. Use of Picosecond Laser for Melasma Treatment: A Narrative Review.
Pimentel B; Palmeiro A; Castro C; Silva L; Catorze MG; João AL
Photobiomodul Photomed Laser Surg; 2023 Dec; 41(12):674-682. PubMed ID: 38085187
[No Abstract] [Full Text] [Related]
14. Efficacy of Long-Pulsed Nd:YAG Laser for Classic Kaposi's Sarcoma: A Dermoscopic Study.
Bostanci S; Aygun Alizada M; Farabi B; Akay BN
Dermatol Pract Concept; 2024 Apr; 14(2):. PubMed ID: 38552137
[TBL] [Abstract][Full Text] [Related]
15. Does Systemic Metformin Have a Role in Treating Melasma?
Ismail SA; Mohamed GA; Mohamedeen KN; Sotohy RSA; Bakr RM
Dermatol Surg; 2024 Apr; 50(4):366-371. PubMed ID: 38416809
[TBL] [Abstract][Full Text] [Related]
16. A prospective comparative study of efficacy and safety of 15% trichloroacetic acid peel, 35% glycolic acid peel and Q-switched Nd-YAG laser in patients of macular amyloidosis.
Vaghasia A; Kamat S; Kansara K; Dharmender J; Shah BJ
J Cutan Aesthet Surg; 2024; 17(1):41-49. PubMed ID: 38736865
[TBL] [Abstract][Full Text] [Related]
17. Topical isoniazid as a novel treatment for melasma: A randomized, double-blind, vehicle-controlled clinical trial.
Ahramiyanpour N; Mahmoudi Z; Nezhad NZ; Khazaeli P; Amiri R; Kasraee B
J Cosmet Dermatol; 2024 Apr; ():. PubMed ID: 38581222
[TBL] [Abstract][Full Text] [Related]
18. Targeting the dermis for melasma maintenance treatment.
Han HJ; Kim JC; Park YJ; Kang HY
Sci Rep; 2024 Jan; 14(1):949. PubMed ID: 38200171
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of low intensity Nd: YAG laser and traditional drugs in the treatment of myofascial pain].
Li X; Zhao N; Liu ZL; Zhang SY; Cai Z; Zhu C
Shanghai Kou Qiang Yi Xue; 2023 Jun; 32(3):261-265. PubMed ID: 37803980
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis.
Mongkhon P; Ruengorn C; Awiphan R; Phosuya C; Ruanta Y; Thavorn K; Jamjanya S; Chuamanochan M; Nochaiwong S
Front Pharmacol; 2023; 14():1281050. PubMed ID: 38192412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
